Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population‐based cohort
19931.1k citationsP. James B. Dyck, Jeannine L. Karnes et al.Neurologyprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of P. C. OʼBrien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. C. OʼBrien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. C. OʼBrien more than expected).
This network shows the impact of papers produced by P. C. OʼBrien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. C. OʼBrien. The network helps show where P. C. OʼBrien may publish in the future.
Co-authorship network of co-authors of P. C. OʼBrien
This figure shows the co-authorship network connecting the top 25 collaborators of P. C. OʼBrien.
A scholar is included among the top collaborators of P. C. OʼBrien based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with P. C. OʼBrien. P. C. OʼBrien is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Waring, Stephen C., Walter A. Rocca, Ronald C. Petersen, et al.. (1999). Postmenopausal estrogen replacement therapy and risk of AD. 52(5).20 indexed citations
7.
Stolp‐Smith, Kathryn A., Elizabeth J. Atkinson, Mary E. Campion, P. C. OʼBrien, & Moses Rodriguez. (1998). Health care utilization in multiple sclerosis. Neurology. 50(6). 1594–1600.48 indexed citations
8.
Rodriguez, Moses, Aksel Sıva, Shelley A. Cross, P. C. OʼBrien, & L. T. Kurland. (1995). Optic neuritis. Neurology. 45(2). 244–250.202 indexed citations
Ballard, David, et al.. (1994). Referral selection bias in the Medicare hospital mortality prediction model: are centers of referral for Medicare beneficiaries necessarily centers of excellence?. PubMed. 28(6). 771–84.46 indexed citations
12.
Sıva, Aksel, K. Radhakrishnan, L. T. Kurland, et al.. (1993). Trauma and multiple sclerosis. Neurology. 43(10). 1878–1878.28 indexed citations
13.
Dyck, P. James B., Jeannine L. Karnes, William J. Litchy, et al.. (1993). The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population‐based cohort. Neurology. 43(4). 817–817.1076 indexed citations breakdown →
Lavine, Lawrence, John C. Steele, N. Wolfe, et al.. (1991). Amyotrophic lateral sclerosis/parkinsonism-dementia complex in southern Guam: is it disappearing?. PubMed. 56. 271–85.18 indexed citations
OʼBrien, P. C., et al.. (1989). Otitis media and hearing loss in the children of the Ruatoki valley: a continuing public health problem.. PubMed. 102(865). 160–1.9 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.